The Journal of the Association of Physicians of India
-
J Assoc Physicians India · Aug 2013
Randomized Controlled Trial Multicenter StudyEfficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis.
Ulinastatin is reported to inhibit pro-inflammatory markers and also inhibits coagulation and fibrinolysis. The drug is available in East Asia for the treatment of acute pancreatitis. ⋯ Ulinastatin prevents new organ dysfunction and reduces mortality in subjects with severe pancreatitis.